Embed

Academic

Authors

Cezary Szczylik

Cezary Szczylik,Nicolaus Copernicus University,Oncology,Urology,Pharmacology

Edit

Cezary Szczylik

Nicolaus Copernicus University

Publications: 86 | Citations: 3477

Fields: Oncology, Urology, Pharmacology

Collaborated with 339 co-authors from 1992 to 2012 | Cited by 6308 authors

Cumulative Annual

Sort by:

Publications (86)

BibTeX | RIS | RefWorks Download

Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines

, , , ,

Journal: Kidney & Blood Pressure Research - KIDNEY BLOOD PRESSURE RES , vol. 35, pp. 18-25, 2012

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study (Citations: 1)

, ,

Journal: Gynecologic Oncology - GYNECOL ONCOL , vol. 123, no. 1, pp. 33-36, 2011

7114 POSTER DISCUSSION Appropriateness of Treatment Options for the Management of Patients With Advanced Renal Cell Carcinoma (RCC) Using the Validated Semi Quantitative RAND Corporation/University of California, Los Angeles (RAND/UCLA) Methodology

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=49470332&selfId1=23614295&selfId2=0&maxNumber=12&query=

Journal: European Journal of Cancer - EUR J CANCER , vol. 47, pp. S508-S509, 2011

Efficiency of Supersaturated Calcium Phosphate Mouth Rinse Treatment in Patients Receiving High-Dose Melphalan or BEAM Prior to Autologous Blood Stem Cell Transplantation: A Single-Center Experience

, , , , , ,

Journal: Transplantation Proceedings - TRANSPLANT PROC , vol. 43, no. 8, pp. 3111-3113, 2011

718 SORAFENIB (SOR) DOSAGE PATTERNS IN OLDER PATIENTS (PTS) WITH ADVANCED RENAL CELL CARCINOMA (RCC): A SUBANALYSIS BY AGE OF AN INTEGRATED DATABASE OF 8 COMPANY-SPONSORED CLINICAL TRIALS

, , , , , , , , , ,

Journal: European Urology Supplements - EUR UROL SUPPL , vol. 10, no. 2, pp. 229-229, 2011

Sort by:

Citations (3477 times by 1736 publications)

Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines

, , , , , , , , , , ,

Journal: Oncogene , vol. 31, no. 13, pp. 1683-1694, 2012

A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study

, , , , , , , , ,

Journal: Prostate Cancer and Prostatic Diseases - PROSTATE CANCER PROSTATIC DIS , vol. 15, no. 1, pp. 87-92, 2012

Phase I Trial of Sorafenib in Combination With 5Fluorouracil/Leucovorin in Advanced Solid Tumors

, , , , , , ,

Journal: Journal of Clinical Pharmacology - J CLIN PHARMACOL , vol. 52, no. 5, pp. 656-669, 2012

Chronic VEGF Blockade Worsens Glomerular Injury in the Remnant Kidney Model

, , , , , , ,

Journal: PLOS One , vol. 7, no. 6, 2012

Agents That Stabilize Mutated von Hippel–Lindau (VHL) Protein: Results of a High-Throughput Screen to Identify Compounds That Modulate VHL Proteostasis

, , , , , , , , ,

Journal: Journal of Biomolecular Screening - J BIOMOL SCREEN , vol. 17, no. 5, pp. 572-580, 2012

Comments

Co-authors (339)

Journals (37)

Keywords (170)

Cezary Szczylik,Nicolaus Copernicus University,Oncology,Urology,Pharmacology

Publications (86)

BibTeX | RIS | RefWorks Download

Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study (Citations: 1)

7114 POSTER DISCUSSION Appropriateness of Treatment Options for the Management of Patients With Advanced Renal Cell Carcinoma (RCC) Using the Validated Semi Quantitative RAND Corporation/University of California, Los Angeles (RAND/UCLA) Methodology

Efficiency of Supersaturated Calcium Phosphate Mouth Rinse Treatment in Patients Receiving High-Dose Melphalan or BEAM Prior to Autologous Blood Stem Cell Transplantation: A Single-Center Experience

718 SORAFENIB (SOR) DOSAGE PATTERNS IN OLDER PATIENTS (PTS) WITH ADVANCED RENAL CELL CARCINOMA (RCC): A SUBANALYSIS BY AGE OF AN INTEGRATED DATABASE OF 8 COMPANY-SPONSORED CLINICAL TRIALS

Citations (3477 times by 1736 publications)

Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines

A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study

Phase I Trial of Sorafenib in Combination With 5Fluorouracil/Leucovorin in Advanced Solid Tumors

Chronic VEGF Blockade Worsens Glomerular Injury in the Remnant Kidney Model

Agents That Stabilize Mutated von Hippel–Lindau (VHL) Protein: Results of a High-Throughput Screen to Identify Compounds That Modulate VHL Proteostasis


	View FAQ about top research areas and Fields of study

Cezary Szczylik,Nicolaus Copernicus University,Oncology,Urology,Pharmacology

Publications (86) BibTeX | RIS | RefWorks Download

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study (Citations: 1)

Publications (86)

BibTeX | RIS | RefWorks Download